Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorNational Institute of Mental Health, Czech Republic

About this trial

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-subject design for comparison. Patients first complete informed consent and baseline questionnaires and are placed on a waiting list for five weeks. After this period, they are reassigned to the active (experimental) group, which will receive five sessions of exposure therapy in virtual reality over a subsequent five-week period. The treatment effect will be evaluated using pre/post assessments, as well as monitoring adherence to exposure and response prevention assignments.

Eligibility criteria

Qualifiers

Diagnosis of OCD (F42) using currently valid DSM-V and ICD-11

Fluent in Czech

Disqualifiers

Any other psychiatric, neurological and serious somatic illness

Substance abuse

Psychotropic medication (e.g. benzodiazepines) except antidepressants, antipsychotic medication and hypnotics.

Contradictions to using a virtual reality (e.g., epilepsy, balance problems)

Trial design

Treatments tested in this trial

  • exposure therapy in virtual reality
  • Wait list

Treatment groups

30 Participants
are divided into 1 treatment group